BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kogure T, Ueno Y, Kawagishi N, Kanno N, Yamagiwa Y, Fukushima K, Satomi S, Shimosegawa T. The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation. J Gastroenterol 2006;41:1005-10. [PMID: 17096070 DOI: 10.1007/s00535-006-1887-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Akarsu M, Matur M, Karademir S, Unek T, Astarcioglu I. Cost Analysis of Liver Transplantation in Turkey. Transplantation Proceedings 2011;43:3783-8. [DOI: 10.1016/j.transproceed.2011.09.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
2 Karnsakul W, Intihar P, Konewko R, Roy A, Colombani PM, Lau H, Schwarz KB. Living donor liver transplantation in children: A single North American center experience over two decades. Pediatr Transplant. 2012;16:486-495. [PMID: 22672018 DOI: 10.1111/j.1399-3046.2012.01725.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
3 Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep 2013;15:301. [PMID: 23250701 DOI: 10.1007/s11894-012-0301-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
4 Oberkofler CE, Dutkowski P, Stocker R, Schuepbach RA, Stover JF, Clavien PA, Béchir M. Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Crit Care. 2010;14:R117. [PMID: 20550662 DOI: 10.1186/cc9068] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
5 Lai JC, Pichardo EM, Emond JC, Brown RS. Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center. Am J Transplant. 2009;9:586-591. [PMID: 19191773 DOI: 10.1111/j.1600-6143.2008.02511.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
6 Clemente W, Romanelli R, Faria L, Lima S, Jesus L, Cortes J, Sanches M, Cançado O, Lima A. Impact of Model for End-Stage Liver Disease in the Occurrence of Infectious Events and Survival in a Cohort of Liver Transplant Recipients. Transplantation Proceedings 2013;45:297-300. [DOI: 10.1016/j.transproceed.2012.02.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Hwang S, Lee SG, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Kim KW, Choi NK. An increase in deceased donor incidence alleviated the need for urgent adult living donor liver transplantation in a Korean high-volume center. Transplant Proc. 2010;42:1497-1501. [PMID: 20620462 DOI: 10.1016/j.transproceed.2009.12.059] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
8 Bruns H, Hillebrand N, Schneider T, Hinz U, Fischer L, Schmidt J, Goldschmidt AJ, Schemmer P. LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience. Clin Transplant 2011;25:E558-65. [PMID: 21585550 DOI: 10.1111/j.1399-0012.2011.01483.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
9 van der Hilst CS, Ijtsma AJ, Slooff MJ, Tenvergert EM. Cost of liver transplantation: a systematic review and meta-analysis comparing the United States with other OECD countries. Med Care Res Rev. 2009;66:3-22. [PMID: 18981263 DOI: 10.1177/1077558708324299] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
10 Ishizaki Y, Kawasaki S. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol 2008;43:18-26. [DOI: 10.1007/s00535-007-2141-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
11 Popescu I. Living donor liver transplantation for hepatocellular carcinoma: defining criteria to extend indications. Dig Dis Sci. 2009;54:199-200. [PMID: 18629641 DOI: 10.1007/s10620-008-0386-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Sakata H, Tamura S, Sugawara Y, Kokudo N. Cost analysis of adult-adult living donor liver transplantation in Tokyo University Hospital. Journal of Hepato-Biliary-Pancreatic Sciences 2011;18:184-9. [DOI: 10.1007/s00534-010-0326-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ichida T, Narita Y, Murakami R. Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation. J Gastroenterol 2006;41:1023-4. [DOI: 10.1007/s00535-006-1959-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Li C, Wen T, Yan L, Li B, Wang W, Xu M, Yang J, Wei Y. Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation? Transplantation Proceedings 2010;42:3620-3. [DOI: 10.1016/j.transproceed.2010.07.100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]